References
Brooks, R., R. Rabin, and F. de Charro, eds. 2003. The Measurement and Valuation of Health Status Using the EQ-5D: European Perspective. (Evidence from the EuroQol BIOMED research program.) Dordrecht, Netherlands: Kluwer Academic Publishers.
M. J. Buxton, M. F. Drummond, B. A. Van Hout, R. L. Prince, T. A. Sheldon, T. Szucs and M. Vray. 1997. Modeling in Economic Evaluation: An Unavoidable Fact of Life Health Economics 6: 3 217 - 27 (PubMed)
K. Claxton, M. Sculpher and M. F. Drummond. 2002. A Rational Framework for Decision Making by the National Institute for Clinical Excellence (NICE) Lancet 360: 9334 711 - 15 (PubMed)
P. Dolan and M. Jones-Lee. 1997. The Time Trade-Off: A Note on the Effect of Lifetime Reallocation of Consumption and Discounting Journal of Health Economics 16: 731 - 39 (PubMed)
Drummond, M. F., B. O'Brien, G. L. Stoddart, and G. W. Torrance. 1997. Methods for the Economic Evaluation of Health Care Programmes. Oxford, U.K.: Oxford Medical Publications.
Fox-Rushby, J. A. 2002. Disability-Adjusted Life Years (DALYs) for Decision-Making? London: Office of Health Economics.
J. Gabbay and A. le May. 2004. Evidence Based Guidelines or Collectively Constructed `Mindlines?' Ethnographic Study of Knowledge Management in Primary Care British Medical Journal 329: 7473 1013 (PubMed)
Glick, H., D. Polsky, and K. Schulman. 2001. "Trial-Based Economic Evaluations: An Overview of Design and Analysis." In Economic Evaluation in Health Care: Merging Theory with Practice, ed. M. Drummond and A. McGuire, 113-40. Oxford, U.K.: Oxford University Press.
Gold, M. R., J. E. Siegel, L. B. Russell, and M. C. Weinstein, eds. 1996. Cost-Effectiveness in Health and Medicine. New York: Oxford University Press.
C. Hoffmann, B. A. Stoykova, J. Nixon, J. M. Glanville, K. Misso and M. F. Drummond. 2002. Do Health-Care Decision Makers Find Economic Evaluations Useful? The Findings of Focus Group Research in U.K. Health Authorities Value Health 5: 2 71 - 78 (PubMed)
iMTA (Institute for Medical Technology Assessment). 2005. Newsletter 3: 1 1 - 3
Jamison, D. T. 2002. "Cost-Effectiveness Analysis: Concepts and Applications." In Oxford Textbook of Public Health, 4th ed., ed. R. G. Detels, J. McEwen, R. Beaglehole, and H. Tanaka, 903-19. Oxford, U.K.: Oxford University Press. Also published as Disease Control Priorities Project Reprint 3.
Jamison, D. T., and J. S. Jamison. 2003. "Discounting." Disease Control Priorities Project Working Paper 4, World Bank, Washington, DC.
Jamison, D. T., W. H. Mosley, A. R. Measham, and J. L. Bobadilla, eds. 1993. Disease Control Priorities in Developing Countries. New York: Oxford University Press.
G. Karlsson and M. Johannesson. 1996. The Decision Rules of Cost-Effectiveness Analysis Pharmacoeconomics 9: 2 113 - 20 (PubMed)
Kuntz, K. M., and M. C. Weinstein. 2001. "Modelling in Economic Evaluation." In Economic Evaluation in Health Care: Merging Theory with Practice, ed. M. Drummond and A. McGuire, 141-71. Oxford, U.K.: Oxford University Press.
Mathers, C. D., A. Lopez, C. Stein, D. Ma Fat, C. Rao, M. Inoue, and others. 2005. "Deaths and Disease Burden by Cause: Global Burden of Disease Estimates for 2001 by World Bank Country Groups." Disease Control Priorities Project Working Paper 18, World Bank, Washington, DC.
D. McDaid, R. Cookson and ASTEC Group. . 2003. Evaluating Health Care Interventions in the European Union Health Policy 63: 2 133 - 39 (PubMed)
Morgenstern, O. 1963. On the Accuracy of Economic Observations. Princeton, N.J.: Princeton University Press.
Mulligan, J., J. A. Fox-Rushby, T. Adam, B. Johns, and A. Mills. 2003. "Unit Costs of Health Care Inputs in Low and Middle Income Regions." Disease Control Priorities Project Working Paper 9, World Bank, Washington, DC.
Murray, C. J. L. 1996."Rethinking DALYs." In The Global Burden of Disease, ed. C. J. L. Murray and A. D. Lopez, 1-98. Cambridge, MA: Harvard University Press.
Murray, C. J. L., and A. D. Lopez, eds. 1996. The Global Burden of Disease. Cambridge, MA: Harvard University Press.
P. Musgrove. 1999. Public Spending on Health Care: How Are Different Criteria Related? Health Policy 47: 207 - 23 (PubMed)
———2000. A Critical Review of `A Critical Review': The Methodology of the 1993 World Development Report, Investing in Health Health Policy and Planning 15: 1 110 - 15 (PubMed)
NICE (National Institute for Clinical Excellence). 2004. Guide to the Methods of Technology Appraisal. London: NICE. http://www.nice.org.uk.
T. A. Sheldon, N. Cullum, D. Dawson, A. Lankshear, K. Lowson, I. Watt , et al. , et al.. 2004. What's the Evidence That NICE Guidance Has Been Implemented? Results from a National Evaluation Using Time Series Analysis, Audit of Patients' Notes, and Interviews British Medical Journal 329: 7473 999 (PubMed)
Sloan, F. A. 1995. "Introduction." In Valuing Health Care: Costs, Benefits, and Effectiveness of Pharmaceuticals and Other Technologies, ed. F. A. Sloan. New York: Cambridge University Press.
Smith, P. C. 2005. "Statutory Packages of Health Care Alongside Voluntary Insurance: What Treatments Should Be Covered?" York, U.K.: Centre for Health Economics, University of York.
R. Taylor and NICE (National Institute for Clinical Excellence). . 2002. HTA Rhyme and Reason? International Journal of Technology Assessment in Health Care 18: 2 166 - 70 (PubMed)
D. Walker and J. A. Fox-Rushby. 2000. Critical Review of Economic Evaluations of Communicable Disease Interventions in Developing Countries Health Economics 9: 8 681 - 98 (PubMed)
WHO (World Health Organization). 2000. World Health Report 2000. "Health Systems: Improving Performance." Geneva: WHO.
S. Wordsworth and A. Ludbrook. 2004. Comparing Costing Results in Across Country Economic Evaluations: The Use of Technology Specific Purchasing Power Parities Health Economics 14: 1 93 - 96
World Bank. 1993. World Development Report: Investing in Health. New York: Oxford University Press.
———. 2003. World Development Indicators. Washington, DC: World Bank.
